Gurtaps Pharma OPC Private Limited

Gurtaps Pharma OPC Private Limited - pharma in Jammu, Jammu And Kashmir, India. FY 2026 financials & compliance.
CIN U24230JK2015OPC004516 Incorporated 09 October 2015 ROC Jammu HQ Jammu, Jammu And Kashmir, India
Active pharma MSME · Micro
Data last updated
Revenue · FY 2023
₹53.41 Lakh
▲ 8% YoY
Net profit · FY 2023
₹2.34 Lakh
Net margin 4.4%
EBITDA · FY 2023
₹2.34 Lakh
EBITDA margin 4.4%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
11 yrs
Est. 2015
Directors on board
1
As per MCA filings
Active GSTINs
1
GST registered

About Gurtaps Pharma OPC Private Limited

Data last updated:

Gurtaps Pharma OPC Private Limited is a one person company based in Jammu, Jammu And Kashmir, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 09 October 2015 and has been in existence for over 11 years.

The company is registered with the Registrar of Companies (ROC), Jammu, under CIN U24230JK2015OPC004516. Its GSTIN is 01AAGCG5309K1ZT (Jammu and Kashmir).

The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by director Dilbag Singh.

Its latest financial statements are for the year ended 31 March 2023. The registered office is at Gangyal, Jammu, Jammu and Kashmir, India – 180010.

As per the financials filed for FY 2023, the company reported a revenue of ₹53.41 Lakh, a growth of 8% compared to the previous year. For the same year it recorded a net profit of ₹2.34 Lakh (net margin 4.4%) and EBITDA of ₹2.34 Lakh (EBITDA margin 4.4%). Revenue has grown at a compounded annual rate (CAGR) of 2% over three years.

Gurtaps Pharma OPC Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-JK-03-0008547). The current compliance status is marked as active non-compliant by the Registrar of Companies.

Company details

CIN U24230JK2015OPC004516
Registration Number 004516
Incorporation Date 09 October 2015
ROC Jammu
Listing Status Unlisted
Company Status Active
Date of Balance Sheet 31 March 2023
Compliance Status Active Non-Compliant
MSME Classification Micro
Udyam Registration UDYAM-JK-03-0008547

Recognitions & Rankings of Gurtaps Pharma OPC

MSME (Udyam registered) Ministry of MSME
Category
Micro (2021-22)
Udyam number
UDYAM-JK-03-0008547

Contact details

Gurtaps Pharma OPC Private Limited's registered office is in Jammu, Jammu And Kashmir. Its e-mail address is in the company report.

  • Email
  • Registered Address
    Gangyal, Jammu, Jammu and Kashmir, India – 180010
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Gurtaps Pharma OPC Private Limited, buy the company report.

Comprehensive company report
Gurtaps Pharma OPC Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Gurtaps Pharma OPC is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Gurtaps Pharma OPC Private Limited, buy the company report.

Financials of Gurtaps Pharma OPC Private Limited

FY 2023 filings available

Gurtaps Pharma OPC Private Limited reported revenue of ₹53.41 Lakh (up 8% YoY) for FY 2023.

Revenue · FY 2023
₹53.41 Lakh ▲ 8%
Net profit · FY 2023
₹2.34 Lakh margin 4.4%
EBITDA · FY 2023
₹2.34 Lakh margin 4.4%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 8%
3 years · compounded
▲ 2%
EBITDA CAGR growth
1 year
▼ 11%
3 years · compounded
▲ 144%

Revenue has grown at a compounded annual rate (CAGR) of 2% over three years, including 8% growth in the latest year. EBITDA fell 11% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2022-23FY 2021-22FY 2020-21FY 2019-20FY 2018-19
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹2.34 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹2.34 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2022-23FY 2021-22FY 2020-21FY 2019-20FY 2018-19
Profitability
EBITDA Margin4.4%
Net Profit Margin4.4%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Gurtaps Pharma OPC Private Limited, buy the company report.

Board of directors of Gurtaps Pharma OPC Private Limited

Gurtaps Pharma OPC has 1 director on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Dilbag SinghDirector09 Oct 201511 Years 0 MonthsCurrent

MSME payment delays

No delayed payments to MSME suppliers are on our record for Gurtaps Pharma OPC Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Gurtaps Pharma OPC has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
01AAGCG5309K1ZTJammu and KashmirActive09 Jan 2018

To see the full GST registrations and return filing status of Gurtaps Pharma OPC Private Limited, buy the company report.

Recent activity

Gurtaps Pharma OPC Private Limited has 1 board change on record since 2015: 1 appointment. The latest: Dilbag Singh was appointed as Director on 09 Oct 2015.

Filing
Gurtaps Pharma Opc Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Jammu.
Appointed
Dilbag Singh was appointed as Director.
Incorporation
09 Oct 2015
Gurtaps Pharma Opc Private Limited was registered on 09 Oct 2015 with Roc Jammu & aged 11 years 18 days as per MCA records.

Frequently asked questions

Gurtaps Pharma OPC is an active company based in Jammu, Jammu And Kashmir, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 09 October 2015 (11+ years old) and is registered under CIN U24230JK2015OPC004516.

Gurtaps Pharma OPC has 1 current director:

The latest financial statements of Gurtaps Pharma OPC on record with the MCA are for the year ended 31 March 2023. Year-wise statements from FY 2016 are in the company report.

The GSTIN of Gurtaps Pharma OPC is 01AAGCG5309K1ZT, registered in Jammu and Kashmir.

The CIN (Corporate Identification Number) of Gurtaps Pharma OPC is U24230JK2015OPC004516. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Gurtaps Pharma OPC was incorporated on 09 October 2015, making it 11+ years old. It is registered with the Registrar of Companies, Jammu.

Dilbag Singh was appointed as Director on 09 Oct 2015.

Yes, Gurtaps Pharma OPC is registered as a micro enterprise under Udyam registration (number: UDYAM-JK-03-0008547).

The registered office of Gurtaps Pharma OPC is at Gangyal, Jammu, Jammu and Kashmir, India – 180010.

Gurtaps Pharma OPC operates in the pharma industry, in the drug formulation and development segment.